No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

American Orthopedic Partners Adds Ted Schlegel, MD As Sr VP, Clinical Excellence

Editor: What To Know

  • The physician-centric culture at AOP enables partners to lead the strategic, business, and clinical aspects of their practice with a collaborative approach to problem-solving, a shared vision of clinical excellence, peer engagement to propel evidence-based practice, an active voice in decision-making, and resources that foster growth and access to care.
  • He completed his residency training in orthopedic surgery at the University of Utah, followed by a sports medicine fellowship at the Steadman Hawkins Clinic in Vail, CO.
  • In 2016, under his leadership, Steadman Hawkins Clinic established a strategic partnership with UCHealth and the University of Colorado School of Medicine to create a state-of-the-art orthopedic facility for sports medicine.

American Orthopedic Partners (AOP) today announced Dr. Ted Schlegel joins the practice as Senior Vice President, Clinical Excellence.

In his new position at AOP, Dr. Schlegel will ensure the delivery of clinical excellence by providing leadership and subject matter expertise for clinical innovation and the development of best practices. He will share with his colleagues across AOP evidence-based practices and strategic clinical program initiatives so that AOP delivers the best possible clinical value and outcomes to its patients across the country. Dr. Schlegel comes to AOP with nearly 30 years in the clinical and academic settings in orthopedic medicine; and he knows first-hand the challenges orthopedic surgeons face in the rapidly evolving healthcare environment.

Most recently, Dr. Schlegel was a practicing orthopedic surgeon at Steadman Hawkins Clinic in Denver, a practice he co-founded. In 2016, under his leadership, Steadman Hawkins Clinic established a strategic partnership with UCHealth and the University of Colorado School of Medicine to create a state-of-the-art orthopedic facility for sports medicine. Dr. Schlegel served as Fellowship Director for the sports medicine program at UCHealth Steadman Hawkins Clinic and Director of Research and Innovation for the UC Inverness Center. After retiring from his clinical surgical practice, he was honored with the Emeritus Associate Professor position in the Department of Orthopedics at the University of Colorado School of Medicine.

Dr. Schlegel’s clinical work and research on regenerative treatments of the knee and shoulder led to the development of several innovative technologies; including the creation of an FDA-approved surgical technology (Opus Medical) that simplifies arthroscopic rotator cuff repairs. Dr. Schlegel also worked on a novel technique for treating partial thickness rotator cuff tears using a patented collagen scaffold (Rotational Medical).

During his 18 years’ tenure as the team physician for the Denver Broncos, Dr. Schlegel led several research projects on sports injuries specific to high-level football players, and in 2012, he received the prestigious “Outstanding NFL Team Physician Award.”

More recently, his research interests have focused on evaluating effective strategies for curbing the soaring costs of healthcare delivery. As Co-Founder of the North American Specialty Hospital (NASH), he designed an innovative new health care delivery model that resulted in significant savings for self-funded companies.

Dr. Schlegel earned his Doctor of Medicine (MD) from University of Cincinnati School of Medicine and Bachelor of Arts in Biological Sciences from Brown University. He completed his residency training in orthopedic surgery at the University of Utah, followed by a sports medicine fellowship at the Steadman Hawkins Clinic in Vail, CO.

“We are excited to have Ted join our team. His vast experience in the orthopedic profession will help us continue to build a national orthopedic practice that focuses on quality care and clinical value,” said AOP CEO Jay Bronner. “We are passionate about building a strong future for practices that join AOP and Ted will help us do just that,” he added.

“AOP’s unique model makes so much sense – it’s physician-owned and physician led – giving patients the confidence in their care under our leadership,” said Dr. Schlegel. “Together, I’m confident AOP’s experienced team will transform how orthopedics is practiced – with scale, innovation, strong leadership, and most importantly quality care and clinical value,” he added.

The physician-centric culture at AOP enables partners to lead the strategic, business, and clinical aspects of their practice with a collaborative approach to problem-solving, a shared vision of clinical excellence, peer engagement to propel evidence-based practice, an active voice in decision-making, and resources that foster growth and access to care.

AOP leadership believes physicians are best equipped to improve outcomes and reduce costs in healthcare. Physicians who join AOP help build clinical value, lead the orthopedic specialty, define meaningful clinical metrics, set national standards for best practices, with a continued focus on patient-centric care. To date, AOP has partnered with orthopedic practices in California, Illinois, New Jersey, and is continuing its fast growth and the expansion of its national footprint.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy